Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 109126)

Published in Mol Cell Biol on September 01, 1998

Authors

M Faris1, K M Latinis, S J Kempiak, G A Koretzky, A Nel

Author Affiliations

1: Division of Clinical Immunology and Allergy, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90095, USA.

Articles citing this

The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol (2002) 3.08

Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One (2010) 2.45

Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med (2002) 2.15

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A (2003) 1.75

Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol (2002) 1.67

c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol Cell Biol (2000) 1.18

Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med (2000) 1.03

Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol (2009) 1.00

Reactive nitrogen species-induced cell death requires Fas-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol (2004) 0.99

A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol (2000) 0.96

YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. Br J Pharmacol (2008) 0.95

Environmental tobacco smoke suppresses nuclear factor-kappaB signaling to increase apoptosis in infant monkey lungs. Am J Respir Crit Care Med (2006) 0.95

HSP72 can protect cells from heat-induced apoptosis by accelerating the inactivation of stress kinase JNK. Cell Stress Chaperones (2000) 0.92

Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and JNK activation. BMC Cancer (2012) 0.91

Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Br J Pharmacol (2006) 0.87

Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells. Immunology (2010) 0.83

Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis. Proc Natl Acad Sci U S A (2005) 0.83

MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption. Mol Cell Biol (2001) 0.82

Retracted Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells. J Biol Chem (2010) 0.80

Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Oncotarget (2015) 0.79

Protein Kinases and Parkinson's Disease. Int J Mol Sci (2016) 0.75

Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system. J Cancer Res Clin Oncol (2007) 0.75

Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget (2017) 0.75

Articles cited by this

Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (1995) 17.76

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30

Apoptosis by death factor. Cell (1997) 14.42

Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 13.90

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell (1996) 9.93

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (1995) 7.52

Caspases: intracellular signaling by proteolysis. Cell (1997) 7.46

Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (1995) 7.37

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (1996) 6.75

Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (1995) 6.20

Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (1994) 6.07

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med (Berl) (1996) 5.77

TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity (1996) 5.45

Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science (1991) 5.12

Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (1996) 4.92

Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell (1997) 4.39

JNK is involved in signal integration during costimulation of T lymphocytes. Cell (1994) 4.36

The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem (1996) 3.38

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell (1998) 2.81

The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J (1990) 2.74

Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71

Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature (1997) 2.46

c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol (1994) 2.41

A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity (1995) 2.31

Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem (1996) 2.23

The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity (1996) 2.14

Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem (1996) 2.12

Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol (1996) 2.03

Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol (1997) 1.88

FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem (1997) 1.86

Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity (1995) 1.82

Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc Natl Acad Sci U S A (1994) 1.67

Apoptosis meets signal transduction: elimination of a BAD influence. Cell (1996) 1.63

The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood (1996) 1.52

Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol (1995) 1.48

Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci U S A (1997) 1.47

Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol (1997) 1.42

Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J Immunol (1994) 1.34

CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene (1996) 1.33

The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J Immunol (1998) 1.31

c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem (1997) 1.30

Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc Natl Acad Sci U S A (1997) 1.28

Fas modulation of apoptosis during negative selection of thymocytes. Immunity (1996) 1.28

Physiologic activation of T cells via the T cell receptor induces NF-kappa B. J Immunol (1991) 1.27

The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem (1994) 1.22

Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc Natl Acad Sci U S A (1997) 1.16

Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem (1995) 1.13

Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol (1997) 1.11

Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res (1997) 1.06

Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. J Biol Chem (1996) 1.06

Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem (1995) 0.97

A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp Cell Res (1997) 0.96

Increased lymphocyte apoptosis in Fas ligand transgenic mice. J Immunol (1997) 0.80

Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro. Clin Exp Immunol (1993) 0.80

Expression of the tumor necrosis factor gene by dermal fibroblasts in response to ultraviolet irradiation or lipopolysaccharide. J Invest Dermatol (1995) 0.80

Articles by these authors

CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24

Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45. Science (1993) 4.47

Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science (1998) 3.18

Coupling of the TCR to integrin activation by Slap-130/Fyb. Science (2001) 2.26

Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem (1995) 2.22

Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity (1996) 2.18

The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr Biol (1999) 2.10

Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J Biol Chem (1993) 2.02

Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J Biol Chem (1997) 2.00

Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J Exp Med (1996) 1.75

Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur J Immunol (1999) 1.70

Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity (2001) 1.68

Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol (2000) 1.65

Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med (2001) 1.62

Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol (1995) 1.62

Activation of the human RANTES gene promoter in a macrophage cell line by lipopolysaccharide is dependent on stress-activated protein kinases and the IkappaB kinase cascade: implications for exacerbation of allergic inflammation by environmental pollutants. Clin Immunol (1999) 1.60

Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest (1999) 1.56

A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen. J Immunol (1982) 1.52

Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol (1999) 1.46

The molecular adapter SLP-76 relays signals from platelet integrin alphaIIbbeta3 to the actin cytoskeleton. J Biol Chem (2000) 1.43

Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J Biol Chem (1995) 1.42

Differential requirement for SLP-76 domains in T cell development and function. Immunity (2001) 1.36

Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use. AIDS Behav (2012) 1.35

Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J Immunol (1996) 1.34

Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem (1997) 1.33

Molecular interaction between the Fyn-associated protein SKAP55 and the SLP-76-associated phosphoprotein SLAP-130. J Biol Chem (1998) 1.31

The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J Immunol (1998) 1.31

High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav (2012) 1.30

Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic signals. J Immunol (1993) 1.29

Hematopoietic reconstitution of SLP-76 corrects hemostasis and platelet signaling through alpha IIb beta 3 and collagen receptors. Proc Natl Acad Sci U S A (2000) 1.29

Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol Lett (2008) 1.26

Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J Exp Med (2000) 1.21

Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J Biol Chem (1996) 1.21

Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem (1999) 1.21

The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem (1994) 1.20

The adapter protein SLP-76 mediates "outside-in" integrin signaling and function in T cells. Mol Cell Biol (2009) 1.19

Adapter proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol (2000) 1.19

SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activation. J Immunol (1998) 1.16

Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol (2000) 1.16

Functional association between SLAP-130 and SLP-76 in Jurkat T cells. J Biol Chem (2000) 1.15

Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol (1997) 1.11

No time to lose--high throughput screening to assess nanomaterial safety. Nanoscale (2011) 1.11

Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol (1999) 1.10

Regulation of CD45 engagement by the B-cell receptor CD22. Proc Natl Acad Sci U S A (1995) 1.10

Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc Natl Acad Sci U S A (1983) 1.10

Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood (1996) 1.06

SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem (1998) 1.06

Nerve growth factor stimulates the tyrosine phosphorylation of MAP2 kinase in PC12 cells. Neuron (1991) 1.05

Three domains of SLP-76 are required for its optimal function in a T cell line. J Immunol (1997) 1.05

SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J Biol Chem (1999) 1.04

Cutting edge: a novel function for the SLAP-130/FYB adapter protein in beta 1 integrin signaling and T lymphocyte migration. J Immunol (2000) 1.04

In vivo association of Grb2 with pp116, a substrate of the T cell antigen receptor-activated protein tyrosine kinase. J Biol Chem (1994) 1.03

Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J Immunol (1999) 1.03

Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol (1998) 1.00

SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells. J Biol Chem (1997) 0.99

Complexing of the CD-3 subunit by a monoclonal antibody activates a microtubule-associated protein 2 (MAP-2) serine kinase in Jurkat cells. Biochem J (1989) 0.99

CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol (1996) 0.99

Tyrosine phosphorylation of Grb2-associated proteins correlates with phospholipase C gamma 1 activation in T cells. Mol Cell Biol (1996) 0.98

Spontaneous production of interleukin-1 by human alveolar macrophages. Clin Immunol Immunopathol (1983) 0.98

HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J Immunol (1990) 0.97

Signal transduction by the T cell antigen receptor. Semin Immunol (1991) 0.94

Adaptor proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol (1998) 0.93

NK cytokine secretion and cytotoxicity occur independently of the SLP-76 adaptor protein. Eur J Immunol (1999) 0.92

Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73. J Immunol (1994) 0.92

In vivo nasal challenge with diesel exhaust particles enhances expression of the CC chemokines rantes, MIP-1alpha, and MCP-3 in humans. Clin Immunol (2000) 0.91

Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest (1995) 0.90

Signal transduction in T lymphocytes. Clin Exp Rheumatol (1999) 0.86

C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination. Blood (2001) 0.86

In vitro and in vivo macrophage function can occur independently of SLP-76. Int Immunol (2000) 0.86

SLP-76-Cbl-Grb2-Shc interactions in FcgammaRI signaling. Blood (1998) 0.86

CD45 and the immune response. J Am Soc Nephrol (1993) 0.86

Evidence that oxidative stress-induced apoptosis by menadione involves Fas-dependent and Fas-independent pathways. Clin Immunol (2001) 0.86

Primary human CD4+ T cells contain heterogeneous I kappa B kinase complexes: role in activation of the IL-2 promoter. J Immunol (1999) 0.86

Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J Clin Invest (1995) 0.85

TNF-alpha increases ceramide without inducing apoptosis in alveolar type II epithelial cells. Am J Physiol (1999) 0.85

Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex. J Biol Chem (1996) 0.84

Recent developments in lymphocyte activation: linking kinases to downstream signaling events. J Clin Invest (1999) 0.83

SAP: natural inhibitor or grand SLAM of T cell activation? Nat Immunol (2001) 0.83

Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements. J Immunol (1998) 0.83

The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line. Biochem J (1995) 0.83

Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J Immunol (1998) 0.82

Insulin receptor-mediated dissociation of Grb2 from Sos involves phosphorylation of Sos by kinase(s) other than extracellular signal-regulated kinase. J Biol Chem (1998) 0.82

Growth inhibition of a B cell clone mediated by ligation of IL-4 receptors or membrane IgM. J Immunol (1993) 0.82

Signaling events in T lymphocytes leading to cellular activation or programmed cell death. Clin Immunol Immunopathol (1997) 0.82

Surface expression of a heterologous phosphatase complements CD45 deficiency in a T cell clone. J Exp Med (1994) 0.82

A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. J Immunol (1998) 0.81

T cell receptor-induced phosphorylation of Sos requires activity of CD45, Lck, and protein kinase C, but not ERK. J Biol Chem (1997) 0.80

Identification of the sites of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD45. J Biol Chem (1995) 0.80

Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone. J Immunol (1997) 0.80

The role of diacylglycerol kinases in T cell anergy. Ernst Schering Found Symp Proc (2007) 0.80

Intracellular adapter molecules. Semin Immunol (2000) 0.79

The association between CD45 and lck does not require CD4 or CD8 and is independent of T cell receptor stimulation. Biochem Biophys Res Commun (1994) 0.79

Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines. Blood (1997) 0.79

Regulation by CD45 of the tyrosine phosphorylation of high affinity IgE receptor beta- and gamma-chains. J Immunol (1995) 0.79

The need for basic science research education in the medical school curriculum. Proc Assoc Am Physicians (1998) 0.78

Identification of an oligodeoxynucleotide sequence motif that specifically inhibits phosphorylation by protein tyrosine kinases. Antisense Nucleic Acid Drug Dev (1997) 0.78

Restoration of CD2-mediated signaling by a chimeric membrane protein including the cytoplasmic sequence of CD45. Hum Immunol (1994) 0.77